Schelling, M., Avril, N., Naukri, J., Kuhn, W., Romer, W., Sattler, D., Werner, M., Dose, J., Janacek, F., Grief, H. and Schweiger, M. (2000) Positron Emission Tomography Using [¹⁸F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer. Journal of Clinical Oncology, 18, 1689-1695.

has been cited by the following article:

• TITLE: Role of PET-CT (Positron Emission Tomography-Computed Tomography) in Cancer Evaluation and Treatment

  AUTHORS: Balireddy Vasundhara, Pottumuthu Hemalatha, Pakalapati Satya Sarath Kumar Raju

  KEYWORDS: Positron Emission Tomography, Radio Isotopes, Lymphoma, Neo-Plasmas

  JOURNAL NAME: World Journal of Nuclear Science and Technology, Vol.12 No.1, January 11, 2022

  ABSTRACT: Context: Positron emission tomography is a nuclear medicine imaging that deals with physiological function using radioisotopes. With the most PET (Positron Emission Tomography) scanners in integration with the CT scanners of late, this technology has registered phenomenal growth. The small amount of radioactive material is called Radiotracers. Objective: Like 18F- Fluro-deoxy-2-glucose has widely used. In this article, the author introduced clinical applications of PET out of 25 patients who studied hypermetabolic lesions in lymph nodes. Methods: PET imaging is coincidence imaging which is different from the other imaging technique PET image formed from multiple rings of detector crystals. Each decay positron travel in tissue annihilation reaction is going on. FDG is the most commonly used radiotracer to detect and stage various types of malignancies. Result: The field of PET/CT imaging cares for many oncology patients. PET improved localization of malignant lesions. It improved staging biopsy and therapy. Conclusion: Finally, studies to data showed 4% to 10% improvement in the overall accuracy of staging/restaging in lesions. If we use Monte Carlo simulation, OLINDA/EXM software may improve further with widely used.